Peripheral Neuropathy Trial, Recruiting NCT07478367 Sponsor: Istituto Clinico Humanitas Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07478367
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who have been admitted to hospital for an acute (sudden or short-term) illness and are not in an intensive care unit (ICU)
  • For the "critical illness" group: people whose admission involved signs of organ stress or failure, measured by a specific scoring system used by doctors (confirm with trial site for details on how this is assessed)
  • For the "control" group: people whose organ function remained stable throughout their hospital stay, based on the same scoring system
  • People who are able to give written consent to participate

Who may not be able to join:

  • People with a history of nerve damage in the hands or feet, muscle disease, or other conditions affecting the nerves and muscles (such as myasthenia gravis)
  • People with conditions affecting their legs or feet that would prevent certain nerve and muscle tests from being carried out
  • People experiencing severe confusion or agitation that would prevent a medical assessment from taking place
  • People who are in a coma or are otherwise unable to have their muscle strength assessed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pietro E Doneddu, Humanitas Research Institute

Phone: +39 0282247761

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istituto Clinico Humanitas
Registry
ClinicalTrials.gov
Start date
18 November 2025
Est. completion
30 October 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Incidence of CRIMYNE-like neuromuscular involvement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov